In vivo analgesic, anti-inflammatory, sedative, muscle relaxant activities, and docking studies of 3’,4’,7,8-tetrahydroxy-3-methoxyflavone isolated from Pistacia chinensis

Authors

  • Abdur Rauf Department of Chemistry, University of Swabi, Anbar, Khyber Pakhtunkhwa - Pakistan https://orcid.org/0000-0003-2429-5491
  • Umer Rashid Department of Chemistry, COMSATS University Islamabad, Abbottabad Campus, Abbottabad - Pakistan
  • Najla Al Masoud Department of Chemistry, College of Science, Princess Nourah bint Abdulrahman University, Riyadh - Saudi Arabia
  • Zuneera Akram Department of Pharmacology, Faculty of Pharmaceutical Sciences, Baqai Medical University, Karachi - Pakistan https://orcid.org/0000-0002-9884-0520
  • Anees Saeed Department of Chemistry, COMSATS University Islamabad, Abbottabad Campus, Abbottabad - Pakistan https://orcid.org/0009-0004-5596-0401
  • Naveed Muhammad Department of Pharmacy, Abdul Wali Khan University Mardan, Khyber Pakhtunkhwa - Pakistan
  • Taghrid S. Alomar Department of Chemistry, College of Science, Princess Nourah bint Abdulrahman University, Riyadh - Saudi Arabia
  • Saima Naz Department of Biotechnology, Bacha Khan University, Khyber Pakhtunkhwa - Pakistan
  • Marcello Iriti Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan - Italy and National Interuniversity Consortium of Materials Science and Technology (INSTM), Firenze - Italy https://orcid.org/0000-0002-5063-1236

DOI:

https://doi.org/10.33393/dti.2024.2745

Keywords:

Anacardiaceae, Analgesic, Anti-inflammatory, In vivo, Muscle relaxant, Pistacia chinensis, Sedative

Abstract

Background: Pistacia chinensis is extensively employed in traditional medicine. This study aimed to isolate and evaluate the therapeutic effects of 3’4’78-tetrahydroxy-3-methoxyflavone from P. chinensis crude extract.

Materials and Methods: The study utilized column chromatography for isolation. The plant extract and its isolated compound were assessed for in vivo analgesic (hot plate model), anti-inflammatory (carrageenan-induced paw edema), sedative (open field model), and muscle relaxing properties (inclined plane and traction test).

Results: In the thermal-induced analgesic model, a significant analgesic effect was observed for the extract (25, 50, and 100 mg/kg) and the isolated compound (2.5, 5, 10, and 15 mg/kg) at higher doses. The extract (100 mg/kg) significantly prolonged latency time (21.98 seconds) after 120 minutes of administration. The isolated compound elevated the latency time (20.03 seconds) after 30 minutes, remaining significant up to 120 minutes with a latency time of 24.11 seconds. The anti-inflammatory effect showed a reduction in inflammatory reactions by 50.23% (extract) and 67.09% (compound) after the fifth hour of treatment. Both samples demonstrated significant sedative effects, with the extract hindering movement by 54.11 lines crossed compared to the negative control (180.99 lines). The isolated compound reduced the number of lines crossed to 15.23±SEM compared to the negative control. Both samples were also significant muscle relaxants. Docking studies indicated that the compound’s therapeutic effect is due to inhibiting COX and nociceptive pathways.

Conclusion: The isolated compound from Pistacia chinensis exhibits significant analgesic, anti-inflammatory, sedative, and muscle relaxing properties, with potential therapeutic applications by inhibiting COX and nociceptive pathways.

Downloads

Download data is not yet available.

References

Sharma V, Gautam DNS, Radu AF, Behl T, Bungau SG, Vesa CM. Reviewing the traditional/modern uses, phytochemistry, essential oils/extracts and pharmacology of Embelia ribes Burm. Antioxidants. 2022;11(7):1359. https://doi.org/10.3390/antiox11071359 PMID:35883850 DOI: https://doi.org/10.3390/antiox11071359

Dai W, Long L, Wang X, Li S, Xu H. Phytochemicals targeting Toll-like receptors 4 (TLR4) in inflammatory bowel disease. Chin Med. 2022;17(1):53. https://doi.org/10.1186/s13020-022-00611-w PMID:35484567 DOI: https://doi.org/10.1186/s13020-022-00611-w

Kashaninejad M, Tabil LG. Pistachio (Pistacia vera L.). In Yahia EM, ed. Postharvest biology and technology of tropical and subtropical fruits. Cambridge, UK: Woodhead Publishing; 2011: 218-247e. DOI: https://doi.org/10.1533/9780857092618.218

Mir-Makhamad B, Bjørn R, Stark S, Spengler RN III. Pistachio (Pistaciavera L.) domestication and dispersal out of Central Asia. Agronomy (Basel). 2022;12(8):1758. https://doi.org/10.3390/agronomy12081758 DOI: https://doi.org/10.3390/agronomy12081758

Glimn-Lacy J, Kaufman PB. Botany illustrated: introduction to plants, major groups, flowering plant families. Springer; 2006.

Christenhusz MJ, Byng JW. The number of known plants species in the world and its annual increase. Phytotaxa. 2016;261(3):201-217. https://doi.org/10.11646/phytotaxa.261.3.1 DOI: https://doi.org/10.11646/phytotaxa.261.3.1

Anonymous. The wealth of India. A dictionary of Indian raw materials and industrial products publication and information directorate, vol 8. New Delhi: CSIR; 1998:120.

Chopra RN, Chopra IC, Handa KL, Kapur LD. Chopra’s indigenous drugs of India. Academic Publishers; 1994.

Keys JD. Chinese herbs. Tuttle Publishing; 2011 Dec 6.

Huang CY, Chang YY, Chang ST, Chang HT. Xanthine oxidase inhibitory activity and chemical composition of Pistacia chinensis leaf essential oil. Pharmaceutics. 2022;14(10):1982. https://doi.org/10.3390/pharmaceutics14101982 PMID:36297418 DOI: https://doi.org/10.3390/pharmaceutics14101982

De Pooter HL, Schamp NM, Aboutabl EA, El Tohamy SF, Doss SL. Essential oils from the leaves of three Pistacia species grown in Egypt. Flavour Fragrance J. 1991;6(3):229-232. https://doi.org/10.1002/ffj.2730060313 DOI: https://doi.org/10.1002/ffj.2730060313

Nishimuta S. Taki M, Takaishi S, Iijima Y, Akiyama T. Structures of 4-aryl-coumarin (neoflavone) dimers isolated from Pistacia chinensis Bunge and their estrogen-like activity. Chem Pharm Bull (Tokyo). 2000;48(4):505-508. https://doi.org/10.1248/cpb.48.505 PMID:10783069 DOI: https://doi.org/10.1248/cpb.48.505

Chopra RN, Badhwar RK, Ghosh S. Poisonous plants of India. Indian Council of Agricultural Research; 1965:270.

Bibi Y, Zia M, Qayyum A. Review – an overview of Pistacia integerrima a medicinal plant species: ethnobotany, biological activities and phytochemistry. Pak J Pharm Sci. 2015;28(3):1009-1013. PMID:26004708

Rauf A, Rashid U, Shbeer AM, et al. Flavonoids from Pistacia chinensis subsp. integerrima with leishmanicidal activity: computational and experimental evidence. Nat Prod Res. 2023;20:1-6. https://doi.org/10.1080/14786419.2023.2228459 PMID:37357619 DOI: https://doi.org/10.1080/14786419.2023.2228459

Ansari SH, Ali M, Qadry JS. Essential oils of Pistacia integerrima Galls and their effect on the central nervous system. In J Pharmacog 1993; 31(2):89-95. DOI: https://doi.org/10.3109/13880209309082924

Ahmad NS, Waheed A, Farman M, Qayyum A. Analgesic and anti-inflammatory effects of Pistacia integerrima extracts in mice. J Ethnopharmacol. 2010;129(2):250-253. https://doi.org/10.1016/j.jep.2010.03.017 PMID:20359528 DOI: https://doi.org/10.1016/j.jep.2010.03.017

Shirole RL, Shirole NL, Saraf MN. In vitro relaxant and spasmolytic effects of essential oil of Pistacia integerrima Stewart ex Brandis Galls. J Ethnopharmacol. 2015;168:61-65. https://doi.org/10.1016/j.jep.2015.02.001 PMID:25732838 DOI: https://doi.org/10.1016/j.jep.2015.02.001

Noureen F, Khan MR, Shah NA, Khan RA, Naz K, Sattar S. Pistacia chinensis: strong antioxidant and potent testicular toxicity amelioration agent. Asian Pac J Trop Med. 2017;10(4):380-389. https://doi.org/10.1016/j.apjtm.2017.03.027 PMID:28552108 DOI: https://doi.org/10.1016/j.apjtm.2017.03.027

Uddin G, Ismail, Rauf A, et al. Urease inhibitory profile of extracts and chemical constituents of Pistacia atlantica ssp. cabulica Stocks. Nat Prod Res. 2016;30(12):1411-1416. https://doi.org/10.1080/14786419.2015.1062378 PMID:26291657 DOI: https://doi.org/10.1080/14786419.2015.1062378

Wu J-H, Tung Y-T, Chien S-C, et al. Effect of phytocompounds from the heartwood of Acacia confusa on inflammatory mediator production. J Agric Food Chem. 2008;56(5):1567-1573. https://doi.org/10.1021/jf072922s PMID:18254591 DOI: https://doi.org/10.1021/jf072922s

Abu-Izneid T, Rauf A, Akram Z, et al. Discovery of new α-glucosides, antiglycation agent, and in silico study of 2-(3,4-dihydroxyphenyl)-7,8-dihydroxy-3-methoxy-4H-chromen-4-one isolated from Pistacia chinensis. Heliyon. 2024;10(5):e27298. https://doi.org/10.1016/j.heliyon.2024.e27298 PMID:38495136 DOI: https://doi.org/10.1016/j.heliyon.2024.e27298

Rauf A, Akram Z, Naveed M, et al. Studies on the inhibition of ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) by 2-(3, 4-Dihydroxyphenyl)-7, 8-dihydroxy-3-methoxychromen-4-one, a flavonoid from Pistacia chinensis. Chemistry (Basel). 2023;5(4):2094-2103. https://doi.org/10.3390/chemistry5040142 DOI: https://doi.org/10.3390/chemistry5040142

Muhammad N, Saeed M, Khan H. Antipyretic, analgesic and anti-inflammatory activity of Viola betonicifolia whole plant. BMC Complement Altern Med. 2012;12(1):59. https://doi.org/10.1186/1472-6882-12-59 PMID:22551220 DOI: https://doi.org/10.1186/1472-6882-12-59

Law P-Y, Loh HH. Regulation of opioid receptor activities. J Pharmacol Exp Ther. 1999;289(2):607-624. PMID:10215631

Sadiq A, Mahnashi MH, Alyami BA, Alqahtani YS, Alqarni AO, Rashid U. Tailoring the substitution pattern of pyrrolidine-2,5-dione for discovery of new structural template for dual COX/LOX inhibition. Bioorg Chem. 2021;112:104969. https://doi.org/10.1016/j.bioorg.2021.104969 PMID:34023639 DOI: https://doi.org/10.1016/j.bioorg.2021.104969

Muhammad N, Saeed M, Khan H, Haq I. Evaluation of n-hexane extract of Viola betonicifolia for its neuropharmacological properties. J Nat Med. 2013;67(1):1-8. https://doi.org/10.1007/s11418-012-0636-0 PMID:22359189 DOI: https://doi.org/10.1007/s11418-012-0636-0

Javed MA, Ashraf N, Saeed Jan M, et al. Structural modification, in vitro, in vivo, ex vivo, and in silico exploration of pyrimidine and pyrrolidine cores for targeting enzymes associated with neuroinflammation and cholinergic deficit in Alzheimer’s disease. ACS Chem Neurosci. 2021;12(21):4123-4143. https://doi.org/10.1021/acschemneuro.1c00507 PMID:34643082 DOI: https://doi.org/10.1021/acschemneuro.1c00507

Mahnashi MH, Alyami BA, Alqahtani YS, et al. Phytochemical profiling of bioactive compounds, anti-inflammatory and analgesic potentials of Habenaria digitata Lindl.: molecular docking based synergistic effect of the identified compounds. J Ethnopharmacol. 2021 Jun 12;273:113976. https://doi.org/10.1016/j.jep.2021.113976 PMID:33647424 DOI: https://doi.org/10.1016/j.jep.2021.113976

Ullah Q, Ali Z, Rashid U, et al. Involvement of the opioidergic mechanism in the analgesic potential of a novel indazolone derivative: efficacy in the management of pain, neuropathy, and inflammation using in vivo and in silico approaches. ACS Omega. 2023;8(25):22809-22819. https://doi.org/10.1021/acsomega.3c01717 PMID:37396203 DOI: https://doi.org/10.1021/acsomega.3c01717

Jan MS, Ahmad S, Hussain F, et al. Design, synthesis, in-vitro, in-vivo and in-silico studies of pyrrolidine-2,5-dione derivatives as multitarget anti-inflammatory agents. Eur J Med Chem. 2020;186:111863. https://doi.org/10.1016/j.ejmech.2019.111863 PMID:31740050 DOI: https://doi.org/10.1016/j.ejmech.2019.111863

Sattar S, Khan MR, Shah NA, Noureen F, Naz K. Nephroprotective potential of Pistacia chinensis bark extract against induced toxicity in rats. Nus Biosci. 2016;8(2):192-200. https://doi.org/10.13057/nusbiosci/n080210 DOI: https://doi.org/10.13057/nusbiosci/n080210

Muhammad N. In-vivo models for management of pain. Pharmacol Pharm. 2014;5(1):92-96. https://doi.org/10.4236/pp.2014.51014 DOI: https://doi.org/10.4236/pp.2014.51014

Published

2024-06-18

How to Cite

Rauf, A., Rashid, U., Al Masoud, N., Akram, Z., Saeed, A., Muhammad, N., Alomar, T. S., Naz, S., & Iriti, M. (2024). In vivo analgesic, anti-inflammatory, sedative, muscle relaxant activities, and docking studies of 3’,4’,7,8-tetrahydroxy-3-methoxyflavone isolated from Pistacia chinensis. Drug Target Insights, 18(1), 47–53. https://doi.org/10.33393/dti.2024.2745
Received 2023-11-28
Accepted 2024-05-06
Published 2024-06-18

Metrics